Journal of psychiatric research

Daily activity and rest patterns linked to immune and metabolism problems in young people with mood disorders

Updated

Abstract

Higher intradaily variability in rest-activity patterns is associated with increased BMI and other metabolic risk factors in individuals with mood disorders.

  • Increased rest-activity fragmentation correlates with higher BMI, fasting insulin, insulin resistance, and CRP levels across all stages of major mood disorders.
  • Lower relative amplitude in rest-activity rhythms is linked to higher BMI and CRP specifically in individuals with full-threshold disorders.
  • Dampened rest-activity patterns are associated with elevated fasting insulin and insulin resistance in early stages of mood disorders.
  • Higher levels of moderate-to-vigorous physical activity are related to lower BMI, but this association is significant only in individuals with full-threshold disorders.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest EMS is Principal Research Fellow at the Brain and Mind Centre, The University of Sydney. She is Discipline Leader of Adult Mental Health, School of Medicine, University of Notre Dame, and a Consultant Psychiatrist. She was the Medical Director, Young Adult Mental Health Unit, St Vincent's Hospital Darlinghurst until January 2021. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier, Janssen and Eli-Lilly Pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. She was the national coordinator of an antidepressant trial sponsored by Servier. IBH has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He is the Chief Scientific Advisor to, and a 3.2 % equity shareholder in, InnoWell Pty Ltd. InnoWell was formed by the University of Sydney (45 % equity) and PwC (Australia; 45 % equity) to deliver the $30M Australian Government-funded Project Synergy (2017-20) and to lead transformation of mental health services internationally through the use of innovative technologies.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free